MV

Muthamilan Vivekanandhan

Active Director Director DIN 09425024
DIN 09425024 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Muthamilan Vivekanandhan

Data last updated:

Muthamilan Vivekanandhan is a Director at Medigrand Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Medigrand Pharmaceuticals Private Limited reported revenue of ₹1.34 Cr (FY 2022).

DIN 09425024
Primary Designation Director
Industry Pharma
First Appointment 30 Nov 2021
Oldest Company Age 15 yrs
Largest company Medigrand Pharmaceuticals Private Limited · ₹1.34 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20212011₹1.34 Cr (FY 2022)Active

Board colleagues of Muthamilan Vivekanandhan

Directorship timeline

Open interactive timeline →
Medigrand Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Muthamilan Vivekanandhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Muthamilan Vivekanandhan

Muthamilan Vivekanandhan currently holds 1 directorship: Medigrand Pharmaceuticals Private Limited (Director, since 30 Nov 2021, revenue ₹1.34 Cr (FY 2022)).

Muthamilan Vivekanandhan was first appointed on 30 Nov 2021 as Director at Medigrand Pharmaceuticals Private Limited.

The current boards of Muthamilan Vivekanandhan's companies include Ayyakannu Sivakumar (Medigrand Pharmaceuticals Private Limited), Narasimman Suresh (Medigrand Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available